LENCI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 485
EU - Europa 139
AS - Asia 53
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 685
Nazione #
US - Stati Uniti d'America 485
IT - Italia 55
SE - Svezia 32
IE - Irlanda 30
CN - Cina 26
SG - Singapore 22
GB - Regno Unito 8
CI - Costa d'Avorio 7
IN - India 5
DE - Germania 4
UA - Ucraina 3
AT - Austria 2
BE - Belgio 2
FI - Finlandia 2
EU - Europa 1
RU - Federazione Russa 1
Totale 685
Città #
Chandler 94
Des Moines 93
New York 40
Fairfield 33
Dublin 30
Ashburn 29
Ancona 17
Wilmington 17
Houston 13
Ann Arbor 11
Boardman 11
Seattle 11
Turin 11
Woodbridge 11
Jacksonville 10
Lawrence 10
Princeton 10
San Mateo 8
Abidjan 7
Singapore 7
Pune 5
Arnold 4
Cambridge 4
London 4
San Diego 4
Washington 4
Cantu 3
Wuxi 3
Brussels 2
Castelraimondo 2
Fabriano 2
Falconara Marittima 2
Falls Church 2
Guangzhou 2
Helsinki 2
Jiaxing 2
Los Angeles 2
Vienna 2
Wuhan 2
Beijing 1
Bolton 1
Centro 1
Kilburn 1
Mantova 1
Milan 1
Osimo 1
Prescot 1
Shaoxing 1
Shenzhen 1
Tolentino 1
Zibo 1
Totale 538
Nome #
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 100
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 88
Electrolyte disorders in cancer patients: a systematic review 85
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 68
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 62
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 62
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 54
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 53
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 51
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 46
null 31
BRCA mutations and gastrointestinal cancers: When to expect the unexpected? 4
Totale 704
Categoria #
all - tutte 3.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 4 6
2020/202199 0 6 4 20 18 0 0 6 8 7 17 13
2021/202287 1 8 1 4 1 9 8 2 16 11 7 19
2022/2023330 18 30 15 22 11 117 0 13 51 3 43 7
2023/2024147 23 3 7 5 16 59 1 5 0 2 1 25
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 704